PF
Fontana, Pierre
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Angiologie et hémostase : ce qui a changé en 2023 | Revue médicale suisse |  | 2024 | 34 | 0 | ||
| Management of anticoagulation and factor XIII replacement in a patient with severe factor XIII deficiency and recurrent venous thromboembolic disease: case report and review of literature | Research and practice in thrombosis and haemostasis |  | 2024 | 24 | 11 | ||
| Angiologie et hémostase : ce qui a changé en 2022 | Revue médicale suisse | | 2023 | 54 | 1 | ||
| Multicenter evaluation of light transmission platelet aggregation reagents: communication from the ISTH SSC Subcommittee on Platelet Physiology | Journal of thrombosis and haemostasis | | 2023 | 30 | 0 | ||
| Recommendations for the use of andexanet alfa in the management of bleeding in patients on oral factor Xa inhibitors in Switzerland: Guideline from the Working Party Hemostasis of the Swiss Society of Hematology | Swiss medical weekly | | 2023 | 36 | 11 | ||
| Thrombophilia and outcomes of venous thromboembolism in older patients | Research and practice in thrombosis and haemostasis | | 2023 | 45 | 8 | ||
| Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side | CPT: pharmacometrics & systems pharmacology | | 2023 | 77 | 43 | ||
| Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe | Haemophilia | | 2023 | 29 | 0 | ||
| Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban Calibrator | Diagnostics | | 2023 | 20 | 13 | ||
| Coexpression of factor VIII and factor von Willebrand variants in a woman with heavy menstrual bleeding | Blood coagulation & fibrinolysis | | 2023 | 39 | 0 | ||
| Longitudinal profile of estrogen-related thrombotic biomarkers after cessation of combined hormonal contraceptives | Blood | | 2023 | 51 | 0 | ||
| Le pouvoir des itinéraires cliniques : assurer une gestion optimale | Revue médicale suisse | | 2023 | 21 | 0 | ||
| Prothrombotic biomarkers during controlled ovarian stimulation for assisted reproductive technology | Fertility and sterility | | 2023 | 85 | 0 | ||
| Effect of therapeutic anticoagulation on gas exchange in mechanically ventilated COVID-19 patients: A secondary analysis of the COVID-HEP trial | Thrombosis research | | 2023 | 123 | 20 | ||
| Clinicians’ adherence to guidelines for the preoperative management of direct oral anticoagulants in a tertiary hospital: a retrospective study | BMC Anesthesiology | | 2023 | 53 | 19 | ||
| Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT study | CPT: pharmacometrics & systems pharmacology | | 2023 | 38 | 18 | ||
| Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A - A modified Delphi consensus by the ADVANCE Working Group | Haemophilia | | 2023 | 41 | 0 | ||
| Differential impact of tamoxifen and aromatase inhibitors on thrombin generation: the prospective HEMOBREAST cohort | Blood advances | | 2022 | 194 | 131 | ||
| Prothrombinase-Induced Clotting Time to Measure Drug Concentrations of Rivaroxaban, Apixaban, and Edoxaban in Clinical Practice: A Cross-Sectional Study | Life | | 2022 | 45 | 27 | ||
| Angiologie-hémostase - Année 2021 : morceaux choisis | Revue médicale suisse | | 2022 | 40 | 13 | ||
| Place des anticoagulants oraux directs dans le traitement des thromboses veineuses de localisation inhabituelle | Revue médicale suisse | | 2022 | 68 | 8 | ||
| Vers de nouveaux anticoagulants | Revue médicale suisse | | 2022 | 37 | 3 | ||
| Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional Study | Frontiers in cardiovascular medicine | | 2022 | 59 | 61 | ||
| External validation of the MidiCAT variant of thrombography: Comparison with calibrated automated thrombography and study of the centrifugation scheme | Frontiers in cardiovascular medicine | | 2022 | 36 | 9 | ||
| Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trial | Research and practice in thrombosis and haemostasis | | 2022 | 172 | 157 | ||
| New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia | Thrombosis and haemostasis | | 2022 | 87 | 0 | ||
| Population Pharmacokinetic Models for Direct Oral Anticoagulants: A Systematic Review and Clinical Appraisal Using Exposure Simulation | Clinical pharmacology and therapeutics | | 2022 | 100 | 99 | ||
| Saignements d’origine indéterminée : approche diagnostique et thérapeutique | Revue médicale suisse | | 2022 | 26 | 8 | ||
| Improving safety of unfractionated heparin: a retrospective, quasi-experimental, observational study of the impact of a pocket card and a computerised prescription aid tool in the University Hospitals of Geneva | BMJ open | | 2022 | 90 | 46 | ||
| The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology | Journal of Thrombosis and Haemostasis | | 2021 | 150 | 0 | ||
| miR-204-5p and Platelet Function Regulation: Insight into a Mechanism Mediated by CDC42 and GPIIbIIIa | Thrombosis and haemostasis | | 2021 | 36 | 6 | ||
| Do miRNAs Have a Role in Platelet Function Regulation? | Hämostaseologie | | 2021 | 142 | 1 | ||
| Drug-drug interactions with direct oral anticoagulants: practical recommendations for clinicians | The American journal of medicine | | 2021 | 100 | 0 | ||
| Mixing Drugs and Genetics: A Complex Hemorrhagic Cocktail | American Journal of Medicine | | 2021 | 226 | 5 | ||
| Détection de l’athérosclérose asymptomatique, y-a-t-il une place en pratique quotidienne ? | Revue médicale suisse | | 2021 | 30 | 7 | ||
| Automated Thrombin Generation Assay for Rivaroxaban, Apixaban, and Edoxaban Measurements | Frontiers in cardiovascular medicine | | 2021 | 92 | 27 | ||
| A universal anti-Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validation | British Journal of Haematology | | 2021 | 256 | 72 | ||
| Estimating the risk thresholds used by guidelines to recommend postpartum thromboprophylaxis | Journal of Thrombosis and Haemostasis | | 2021 | 182 | 1 | ||
| An Ex Vivo and In Silico Study Providing Insights into the Interplay of Circulating miRNAs Level, Platelet Reactivity and Thrombin Generation: Looking beyond Traditional Pharmacogenetics | Journal of Personalized Medicine | | 2021 | 174 | 77 | ||
| COVID-19 patients often show high-titer non-platelet-activating anti-PF4/heparin IgG antibodies | Journal of thrombosis and haemostasis | | 2021 | 37 | 21 | ||
| Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines | Swiss Medical Weekly | | 2020 | 486 | 196 | ||
| Risque thrombotique veineux induit par le SARS-CoV-2 : prévalence, recommandations et perspectives | Revue médicale suisse | | 2020 | 269 | 125 | ||
| Platelet function test use for patients with coronary artery disease in the early 2020s | Journal of clinical medicine | | 2020 | 141 | 62 | ||
| Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics Consortium | Clinical Pharmacology and Therapeutics | | 2020 | 119 | 57 | ||
| MicroRNA-126 is a regulator of platelet-supported thrombin generation | Platelets | | 2020 | 234 | 192 | ||
| Platelet Transforming Growth Factor-β1 Induces Liver Sinusoidal Endothelial Cells to Secrete Interleukin-6 | Cells | | 2020 | 289 | 123 | ||
| A Unique Case of Acquired Hemophilia A Presenting with Transient Ischemic Attack | Acta Haematologica | | 2020 | 280 | 205 | ||
| Contraception et maladie thromboembolique veineuse | Revue médicale suisse | | 2020 | 181 | 58 | ||
| Platelet Interactions with Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells Lead to Hepatocyte Proliferation | Cells | | 2020 | 290 | 83 | ||
| Suggestions for thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 | Swiss Medical Weekly | | 2020 | 279 | 741 | ||
| An unusual thrombus location in a Heartmate 3TM device with fatal outcome | Perfusion | | 2020 | 246 | 1 | ||
| Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland | Swiss Medical Weekly | | 2020 | 532 | 212 | ||
| Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab | Swiss medical weekly | | 2020 | 126 | 50 | ||
| Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance, and their limitations | Journal of Thrombosis and Haemostasis | | 2020 | 117 | 0 | ||
| Contribution of exome sequencing to the identification of genes involved in the response to clopidogrel in cardiovascular patients | Journal of Thrombosis and Haemostasis | | 2020 | 209 | 1 | ||
| Methods to investigate miRNA function: focus on platelet reactivity | Thrombosis and Haemostasis | | 2020 | 182 | 11 | ||
| Maladies vasculaires périphériques et prévention secondaire : un appel à agir | Revue médicale suisse | | 2019 | 195 | 139 | ||
| Obstetrical and postpartum complications in women with hereditary fibrinogen disorders: a systematic literature review | Haemophilia | | 2019 | 360 | 1 | ||
| Platelets and Platelet‐Derived Extracellular Vesicles in Liver Physiology and Disease | Hepatology Communications | | 2019 | 407 | 213 | ||
| Selective inhibition of Panx1 channels decreases hemostasis and thrombosis in vivo | Thrombosis Research | | 2019 | 347 | 132 | ||
| A high glucose level is associated with decreased aspirin-mediated acetylation of platelet cyclooxygenase (COX)-1 at serine 529: A pilot study | Journal of Proteomics | | 2019 | 450 | 248 | ||
| Functional validation of microRNA-126-3p as a platelet reactivity regulator using human haematopoietic stem cells | Thrombosis and Haemostasis | | 2019 | 437 | 381 | ||
| Management of bleeding and invasive procedures in haemophilia A patients with inhibitor treated with emicizumab (Hemlibra®): Proposals from the French network on inherited bleeding disorders (MHEMO), the French Reference Centre on Haemophilia, in collaboration with the French Working Group on Perioperative Haemostasis (GIHP) | Haemophilia | | 2019 | 184 | 0 | ||
| Thrombin generation and fibrin clot structure after vitamin D supplementation | Endocrine Connections | | 2019 | 317 | 144 | ||
| Towards personalized antithrombotic treatments: focus on P2Y12 inhibitors and direct oral anticoagulants | Clinical Pharmacokinetics | | 2019 | 405 | 2 | ||
| Detection of Anti-Cardiolipin and Anti-β2glycoprotein I Antibodies Differs between Platforms without Influence on Association with Clinical Symptoms | Thrombosis and Haemostasis | | 2019 | 175 | 0 | ||
| Platelet Function Testing or Genotyping: Which Should We Trust? | JACC: Cardiovascular Interventions | | 2019 | 172 | 0 | ||
| Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites | Clinical Pharmacokinetics | | 2018 | 566 | 587 | ||
| Fermeture du foramen ovale perméable : où en sommes-nous en 2018 ? | Revue médicale suisse | | 2018 | 185 | 0 | ||
| Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC) | American Heart Journal | | 2018 | 428 | 118 | ||
| Evaluation of recombinant factor VIIa, tranexamic acid and desmopressin to reduce prasugrel-related bleeding: A randomised, placebo-controlled study in a rabbit model | European Journal of Anaesthesiology | | 2018 | 415 | 5 | ||
| Management of bleeding and emergency invasive procedures in patients on dabigatran: Updated guidelines from the French Working Group on Perioperative Haemostasis (GIHP) - September 2016 | Anaesthesia Critical Care & Pain Medicine | | 2018 | 520 | 209 | ||
| [Angiology and haemostasis. Highlights on some new data in 2017] | Revue médicale suisse | | 2018 | 330 | 66 | ||
| Platelet reactivity in stable cardiovascular patients with chronic kidney disease | Platelets | | 2018 | 456 | 0 | ||
| Traitements antithrombotiques et anomalies constitutionnelles hémorragipares de l'hémostase | Revue médicale suisse | | 2018 | 300 | 106 | ||
| Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT | Archives of Cardiovascular Diseases | | 2018 | 371 | 3 | ||
| Anticoagulation à faible dose : is less more ? | Revue médicale suisse | | 2018 | 236 | 71 | ||
| Effects of plasma transfusions on antithrombin levels after paediatric liver transplantation | Vox Sanguinis | | 2018 | 406 | 3 | ||
| Shotgun proteomics data on the impact of hyperglycaemia on platelet protein acetylation by aspirin | Data in Brief | | 2018 | 392 | 148 | ||
| Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation | Journal of Visualized Experiments | | 2017 | 481 | 1 | ||
| Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients? | American Journal of Medicine | | 2017 | 437 | 0 | ||
| Impact of a product-specific reference standard for the measurement of a PEGylated rFVIII activity: the Swiss Multicentre Field Study | Haemophilia | | 2017 | 429 | 0 | ||
| Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) - September 2015 | Anaesthesia critical care & pain medicine | | 2017 | 456 | 0 | ||
| Impact of rivaroxaban on point-of-care assays | Thrombosis research | | 2017 | 414 | 0 | ||
| Platelets in liver regeneration | ISBT Science Series | | 2017 | 442 | 4 | ||
| Angiologie et hémostase | Revue médicale suisse | | 2017 | 380 | 107 | ||
| Subthalamic nucleus deep brain stimulation for Parkinson's disease in a patient with severe haemophilia A | Haemophilia | | 2017 | 344 | 0 | ||
| A multicenter study to assess the reproducibility of antiphospholipid antibody results produced by an automated system | Journal of thrombosis and haemostasis | | 2017 | 484 | 3 | ||
| Comparative Long-Term Effect of Three Anti-P2Y12 Drugs after Percutaneous Angioplasty: An Observational Study Based on Electronic Drug Adherence Monitoring | Frontiers in Pharmacology | | 2017 | 416 | 166 | ||
| Thromboses veineuses splanchniques | Revue médicale suisse | | 2017 | 372 | 108 | ||
| Pannexin- and Connexin-Mediated Intercellular Communication in Platelet Function | International journal of molecular sciences | | 2017 | 510 | 253 | ||
| TiN x O y coatings facilitate the initial adhesion of osteoblasts to create a suitable environment for their proliferation and the recruitment of endothelial cells | Biomedical materials | | 2017 | 716 | 2 | ||
| Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels | Journal of Thrombosis and Haemostasis | | 2017 | 403 | 0 | ||
| Le défi des maladies vasculaires rares : l'union fait la force ! | Revue médicale suisse | | 2017 | 285 | 89 | ||
| Impact of pneumatic tube system transport for the monitoring of heparin therapy | Thrombosis Research | | 2017 | 414 | 0 | ||
| Pannexin1 Single Nucleotide Polymorphism and Platelet Reactivity in a Cohort of Cardiovascular Patients | Cell communication & adhesion | | 2017 | 502 | 2 | ||
| Effect of long-term adherence to clopidogrel on the VASP-PRI after elective coronary stent implantation: a randomized controlled study | British journal of clinical pharmacology | | 2016 | 446 | 0 | ||
| Modulation of osteoblast behavior on TiNxOy coatings by altering the N/O stoichiometry while maintaining a high thrombogenic potential | Journal of biomaterials applications | | 2016 | 770 | 3 | ||
| Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient data | Thrombosis and haemostasis | | 2016 | 478 | 85 | ||
| Genetics of clopidogrel poor-response | Antiplatelet Therapy in Cardiovascular Disease | | 2016 | 467 | 0 | ||
| New molecular insights into modulation of platelet reactivity in aspirin-treated patients using a network-based approach | Human genetics | | 2016 | 675 | 72 | ||
| Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect | Frontiers in pharmacology | | 2016 | 418 | 192 | ||
| PPM1A Methylation Is Associated With Vascular Recurrence in Aspirin-Treated Patients | Stroke | | 2016 | 472 | 0 | ||
| Anticoagulants oraux directs (ACOD) : une aide à la prescription dans la pratique quotidienne | Revue médicale suisse | | 2016 | 418 | 222 | ||
| Correction of prasugrel-related bleeding by prophylactic transfusion of human platelets in a rabbit model | Transfusion | | 2016 | 453 | 2 | ||
| Aspirin response: Differences in serum thromboxane B2 levels between clinical studies | Platelets | | 2016 | 635 | 1 | ||
| Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach | Clinical pharmacology and therapeutics | | 2016 | 564 | 597 | ||
| Pharmacogenomics of Oral Antithrombotic Drugs | Current pharmaceutical design | 2016 | 561 | 0 | |||
| La maladie thromboembolique veineuse : une pathologie souvent oubliée | Revue médicale suisse | | 2016 | 359 | 115 | ||
| TRAF3 Epigenetic Regulation Is Associated With Vascular Recurrence in Patients With Ischemic Stroke | Stroke | | 2016 | 462 | 0 | ||
| Direct oral anticoagulants: a guide for daily practice | Schweizerische medizinische Wochenschrift | | 2016 | 687 | 356 | ||
| News in angiology and hemostasis | Revue médicale suisse | | 2016 | 506 | 129 | ||
| Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis | Thrombosis and haemostasis | | 2016 | 672 | 504 | ||
| Management of congenital quantitative fibrinogen disorders: a Delphi consensus | Haemophilia | | 2016 | 469 | 0 | ||
| Genetic testing to identify women at risk of venous thromboembolism with contraceptive pills: Evidence or hope-based tool ? | Schweizerische medizinische Wochenschrift | | 2016 | 571 | 232 | ||
| Laboratory testing of Hemostasis | Perioperative Hemostasis | | 2015 | 391 | 292 | ||
| Direct oral anticoagulants: efficacy and safety in patient subgroups | Schweizerische medizinische Wochenschrift | | 2015 | 764 | 418 | ||
| Functional role of a polymorphism in the Pannexin1 gene in collagen-induced platelet aggregation | Thrombosis and haemostasis | | 2015 | 562 | 10 | ||
| A focus on the role of platelets in liver regeneration: do platelet-endothelial cell interactions initiate the regenerative process? | Journal of hepatology | 2015 | 782 | 0 | |||
| Antiplatelet drugs and platelet reactivity: is it time to halt clinical research on tailored strategies? | Expert opinion on pharmacotherapy | | 2015 | 616 | 2 | ||
| Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants | Critical care | | 2015 | 481 | 331 | ||
| Reply to: "The role of platelets in liver regeneration - What don't we know?" | Journal of hepatology | | 2015 | 444 | 0 | ||
| Evidence-Based Choice of P2Y12 Inhibitors in End Stage Renal Disease Patients: A Mini-Review | Current drug metabolism | | 2015 | 580 | 6 | ||
| Large external quality assessment survey on thrombin generation with CAT: further evidence for the usefulness of normalisation with an external reference plasma | Thrombosis research | | 2015 | 431 | 1 744 | ||
| Characterisation of the influences of aspirin-acetylation and glycation on human plasma proteins | Journal of proteomics | | 2015 | 618 | 1 | ||
| Aspirin-mediated acetylation of haemoglobin increases in presence of high glucose concentration and decreases protein glycation | EuPA open proteomics | | 2015 | 460 | 249 | ||
| The Human Diabetes Proteome Project (HDPP): The 2014 update | Translational proteomics | | 2015 | 547 | 264 | ||
| Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: An ex vivo study | Platelets | | 2015 | 529 | 0 | ||
| Suspicion of heparin-induced thrombocytopenia in internal medicine: How appropriate is the ordering of anti-PF4/heparin antibody testing? | Platelets | | 2015 | 621 | 3 | ||
| Fibrin degradation during sonothrombolysis – Effect of ultrasound, microbubbles and tissue plasminogen activator | Journal of drug delivery science and technology | | 2015 | 525 | 0 | ||
| Lack of Effect of Platelet Transfusions and Desmopressin on Intracranial Bleeding in a Patient Receiving Ticagrelor | A & A case reports | | 2015 | 583 | 1 | ||
| Hémostase. Aspirine: une ou deux fois par jour? | Revue médicale suisse | | 2014 | 524 | 0 | ||
| How to manage prasugrel and ticagrelor in daily practice | European journal of internal medicine | | 2014 | 441 | 431 | ||
| Antiplatelet Therapy: Targeting the TxA2 Pathway | Journal of cardiovascular translational research | | 2014 | 573 | 2 | ||
| Impact of high glucose concentration on aspirin-induced acetylation of human serum albumin: An in vitro study | EuPA open proteomics | | 2014 | 425 | 209 | ||
| Sputtered titanium oxynitride coatings for endosseous applications: Physical and chemical evaluation and first bioactivity assays | Applied surface science | | 2014 | 719 | 4 | ||
| Refinement of the cutoff values of the HemosIL AcuStar assay for the detection of anticardiolipin and anti-beta2 glycoprotein-1 antibodies | Journal of thrombosis and haemostasis | | 2014 | 568 | 0 | ||
| Fibrinogen geneva II: a new congenitally abnormal fibrinogen alpha chain (Gly17Asp) with a review of similar mutations resulting in abnormal knob A | Blood coagulation & fibrinolysis | | 2014 | 568 | 3 | ||
| Role of paraoxonase-1 in CYP2C19 loss-of-function carriers | Thrombosis research | | 2014 | 592 | 0 | ||
| Evaluation of the GEM®PCL Plus point-of-care device for neonatal coagulation assessment: An observational study on cord blood | Thrombosis research | | 2014 | 535 | 2 | ||
| Characterization of the platelet granule proteome: Evidence of the presence of MHC1 in alpha-granules | Journal of proteomics | | 2014 | 719 | 3 | ||
| Direct oral anticoagulants in the treatment and long-term prevention of venous thrombo-embolism | European heart journal | | 2014 | 574 | 284 | ||
| Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia | Haematologica | | 2014 | 592 | 2 | ||
| Hémostase : nouveaux anticoagulants oraux : de la théorie à la pratique | Revue médicale suisse | | 2013 | 371 | 0 | ||
| The Human Diabetes Proteome Project (HDPP): From network biology to targets for therapies and prevention | Translational proteomics | | 2013 | 655 | 194 | ||
| Tailored Thienopyridine therapy: no urgency for CYP2C19 genotyping | Journal of the American Heart Association. Cardiovascular and cerebrovascular disease | | 2013 | 532 | 0 | ||
| Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013 | Archives of cardiovascular diseases | | 2013 | 473 | 0 | ||
| Antiplaquettaires et patients âgés : quelles molécules et quelles preuves ? | Revue médicale suisse | | 2013 | 507 | 0 | ||
| Gestion péri-interventionnelle des nouveaux agents antiplaquettaires | Revue médicale suisse | | 2013 | 582 | 261 | ||
| Gestes invasifs et patients sous anticoagulants oraux : to bridge or not to bridge ? | Revue médicale suisse | | 2013 | 471 | 1 | ||
| Thrombotic complications of myeloproliferative neoplasms: risk assessment and risk-guided management | Journal of thrombosis and haemostasis | | 2013 | 613 | 0 | ||
| Unraveling modulators of platelet reactivity incardiovascular patients using omics strategies: Towards anetwork biology paradigm | Translational proteomics | | 2013 | 580 | 500 | ||
| Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study | Circulation | | 2012 | 658 | 8 | ||
| Aspirin for venous thromboembolism prevention and treatment: a renewal? | Polskie Archiwum Medycyny Wewnętrznej | | 2012 | 543 | 268 | ||
| Prevalence of poor biological response to clopidogrel: a systematic review | Thrombosis and haemostasis | | 2012 | 477 | 0 | ||
| Poor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevance and management | Cardiovascular therapeutics | | 2012 | 569 | 0 | ||
| Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis | Journal of thrombosis and haemostasis | | 2012 | 558 | 0 | ||
| The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro | British journal of pharmacology | | 2012 | 511 | 0 | ||
| Platelet proteomics | Mass spectrometry reviews | | 2012 | 465 | 2 | ||
| The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin | Journal of thrombosis and haemostasis | | 2011 | 506 | 0 | ||
| Relationship between paraoxonase-1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study | Journal of thrombosis and haemostasis | | 2011 | 583 | 0 | ||
| Surveillance biologique des héparines et du fondaparinux | Revue médicale suisse | | 2011 | 539 | 4 | ||
| Platelet reactivity is a stable and global phenomenon in aspirin-treated cardiovascular patients | Thrombosis and haemostasis | | 2011 | 595 | 0 | ||
| Connexin 37 limits thrombus propensity by downregulating platelet reactivity | Circulation | | 2011 | 678 | 824 | ||
| Impact of genetic polymorphisms and drug-drug interactions on clopidogrel and prasugrel response variability | Current drug metabolism | 2010 | 606 | 0 | |||
| Hémostase. Le point sur les nouveaux antithrombotiques | Revue médicale suisse | 2010 | 486 | 0 | |||
| Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis | Journal of thrombosis and haemostasis | | 2010 | 482 | 0 | ||
| Maladies cardiovasculaires, antiagrégants, anticoagulants et risque hémorragique | Revue médicale suisse | 2010 | 557 | 0 | |||
| Evaluation de l'efficacité biologique du clopidogrel: génotype ou phénotype? | Revue médicale suisse | 2010 | 475 | 0 | |||
| Antiagregants plaquettaires : lequel, quand et pour qui ? | La Revue de médecine interne | | 2010 | 470 | 0 | ||
| Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study | Journal of thrombosis and haemostasis | | 2010 | 540 | 0 | ||
| Acute coronary syndrome and its antithrombotic treatment: focus on aspirin and clopidogrel resistance | Current vascular pharmacology | 2009 | 464 | 0 | |||
| Cell-derived microparticles in haemostasis and vascular medicine | Thrombosis and haemostasis | 2009 | 469 | 0 | |||
| Diagnosis of mild bleeding disorders | Schweizerische medizinische Wochenschrift | | 2009 | 572 | 991 | ||
| Intercellular communication in atherosclerosis | Physiology | | 2009 | 534 | 0 | ||
| Le concept de "resistance" a l'aspirine: mecanismes et pertinence clinique | La Revue de médecine interne | | 2009 | 502 | 0 | ||
| Platelet hyperreactivity and dual antiplatelet therapy: can biases be avoided? | Journal of thrombosis and haemostasis | | 2009 | 472 | 0 | ||
| No influence of the VAMP8 rs1010 single nucleotide polymorphism on platelet functions in vitro | Journal of Cellular and Molecular Medicine | 2009 | 517 | 0 | |||
| Biological effect of increased maintenance dose of clopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C19*2 allele on clopidogrel responsiveness | Thrombosis research | | 2008 | 563 | 0 | ||
| Impending paradoxical embolism. When and how to treat? | Annales de cardiologie et d'angéiologie | | 2008 | 522 | 0 | ||
| Assessing aspirin responsiveness using the Verify Now Aspirin assay | Thrombosis research | | 2008 | 580 | 0 | ||
| Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis | Journal of thrombosis and haemostasis | | 2008 | 567 | 0 | ||
| Laboratory-defined aspirin resistance and recurrent cardiovascular events | Archives of internal medicine | | 2008 | 527 | 0 | ||
| Aspirin "resistance" and risk of cardiovascular morbidity | BMJ. British medical journal | | 2008 | 462 | 1 | ||
| Aspirin response variability assessed with the PFA-100 device | Thrombosis and haemostasis | 2008 | 565 | 0 | |||
| Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects | Circulation | | 2003 | 208 | 59 |
